Therapeutic Plasma Exchange Market Size, Share & Trends Analysis Report By Product & Technologies (Product (Consumables & Devices) And Technology (Centrifugation & Membrane Separation)), By Indication, By End-Users, Region And Segment Forecasts, 2025-2034

Report Id: 1120 Pages: 180 Last Updated: 18 June 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Therapeutic Plasma Exchange Market is expected to grow at an 5.5% CAGR during the forecast period for 2025-2034.

Therapeutic Plasma Exchange Market INFO

Plasma exchange is a biological procedure that removes large-molecular-weight substances such as harmful antibodies from the plasma. In this procedure, a large portion of plasma containing abnormal matter and toxins are removed from the components of WBCs, RBCs, and platelets and then replaced with replacement fluid, like fresh frozen plasma (FFP) i.e., donor plasma or albumin. It is performed to treat several chronic diseases as the first-line or as second line of treatment therapy in neurological and non-neurological conditions.

Therapeutic plasma exchange (TPE) can rapidly decrease plasma viscosity. Thus, it can improve patient outcomes in critically ill patients with COVID-19 by reducing plasma viscosity and thereby enhancing blood flow.

Global Therapeutic plasma exchange market is expected to offer the lucrative growth in the near future due to the rising prevalence of chronic diseases and ongoing research and clinical trials to determine the efficacy of plasma exchange over other treatments. Also, the outbreak of a new viral disease, COVID – 19, is also creating a massive demand for therapeutic plasma exchange and thereby drive the global market.

Market Segmentation

The Global Therapeutic plasma exchange market is segmented on the basis of product & technologies, end-users, and region. Based on the base of product and technology, the market is divided into the product (consumables & devices) and technology (centrifugation & membrane separation). On the basis of indication, the market is divided into neurological disorders, hematology disorders, renal disorders, and metabolic disorders. On the basis of end-users, the market is divided into blood collection centres & blood component providers, hospitals & transfusion centres, and other end users. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. North America accounted for the largest share of the market in 2019, followed by Europe and Asia Pacific. On the other hand, the Asia Pacific is projected to have the highest growth rate during the forecast period.

Competitive Landscape

Some of The Key Players in The Therapeutic Plasma Exchange Market:

  • Terumo Bct, Inc.
  • Fresenius Se & Co. KGaA
  • Haemonetics Corporation
  • Baxter International Inc.
  • Asahi Kasei Medical Co. Ltd.
  • Braun Melsungen Ag
  • Cerus Corporation
  • Kaneka Corporation
  • Kawasumi Laboratories, Inc.
  • Nikkiso Co., Ltd.
  • Miltenyi Biotec
  • Other Prominent Players

The Therapeutic Plasma Exchange Market Report Scope

Report Attribute Specifications
Growth Rate CAGR CAGR of 5.5% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Million and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Product & Technologies, By Indication, By End-Users
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia
Competitive Landscape Terumo BCT, Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Baxter International Inc., Cerus Corporation, Kaneka Corporation, Kawasumi Laboratories, Inc., Nikkiso Co., Ltd., Miltenyi Biotec, Medica S.p.A., Medicap Clinic GmbH, and Others
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Global Therapeutic Plasma Exchange Market Segmentation:

Global Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Product & Technology,

  • Product
    • Consumables
    • Devices
  • Technology
    • Centrifugation
    • Membrane Separation

Therapeutic Plasma Exchange Market

Global Therapeutic Plasma Exchange Market Revenue (US$ Mn), By Indication, 

  • Neurological Disorders: Guillain–Barré syndrome, Chronic inflammatory demyelinating polyneuropathy, Myasthenia gravis, Multiple sclerosis and PANDASa
  • Hematology Disorders: Thrombotic, thrombocytopenic purpura, Atypical haemolytic uraemic syndrome, Hyperviscosity syndromes and Severe/symptomatic cryoglobulinaemia
  • Renal Disorders: Goodpasture’s syndrome, Wegener’s glomerulonephritis and Antibody-mediated renal transplant rejection
  • Metabolic Disorders: Familial hypercholesterolaemia (homozygous)
  • Other Indications

Global Therapeutic Plasma Exchange Market Revenue (US$ Mn), By End Users, 

  • Blood Collection Centres & Blood Component Providers
  • Hospitals & Transfusion Centres
  • Other End Users

Global Therapeutic Plasma Exchange Market Revenue (US$ Mn), By Region, 

North America Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country,

  • U.S.
  • Canada

Europe Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country,

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country,

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country, 2019-2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country, 2019-2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
7909
Security Code field cannot be blank!

Frequently Asked Questions

Therapeutic Plasma Exchange Market is expected to grow at an 5.5% CAGR during the forecast period for 2025-2034.

Terumo BCT, Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Baxter International Inc., Ce

Product & Technologies, Indication and End-Users are the key segments of the Therapeutic Plasma Exchange Market.

North American region is leading the Therapeutic Plasma Exchange Market.
Get Sample Report Enquiry Before Buying